Spectrum Pharmaceuticals Inc
SPPI
SPPI was delisted on the 31st of July, 2023.
161 hedge funds and large institutions have $373M invested in Spectrum Pharmaceuticals Inc in 2016 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 70 increasing their positions, 22 reducing their positions, and 7 closing their positions.
443% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 7
218% more repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 22
26% more capital invested
Capital invested by funds: $296M → $373M (+$77.1M)
23% more funds holding
Funds holding: 131 → 161 (+30)
20% less call options, than puts
Call options by funds: $646K | Put options by funds: $810K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$14.2M |
| 2 |
Renaissance Technologies
New York
|
+$8.86M |
| 3 |
D.E. Shaw & Co
New York
|
+$6.15M |
| 4 |
State Street
Boston,
Massachusetts
|
+$5.06M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$4.66M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KAM
Krensavage Asset Management
New York
|
-$6.95M |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$1.06M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$959K |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$619K |
| 5 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
-$412K |
SPPI Hedge Fund Activity: Q2 2016 in Review
161 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q2 2016, worth a combined $373M — up 26% from $296M a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new SPPI positions and 7 closed out — a net gain of 31 holders — while 70 added to existing stakes and 22 trimmed.
The largest buyer was Macquarie Group, adding an estimated $14.2M. The largest seller was Krensavage Asset Management, exiting entirely with an estimated $6.95M sold.
- 161 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q2 2016, up from 131 in Q1 2016.
- Funds reported $373M of Spectrum Pharmaceuticals Inc stock for Q2 2016, up 26% quarter-over-quarter.
- 38 funds opened new Spectrum Pharmaceuticals Inc positions in Q2 2016 and 7 closed out, a net change of +31 holders.
- The largest Spectrum Pharmaceuticals Inc buyer in Q2 2016 was Macquarie Group, an estimated $14.2M added.
- The largest Spectrum Pharmaceuticals Inc seller in Q2 2016 was Krensavage Asset Management, an estimated $6.95M sold.
Based on aggregated 13F filings for Q2 2016.